Advertisement

Topics

Make my Day - Primary Prevention of Stroke

2018-11-08 16:48:19 | BioPortfolio

Published on BioPortfolio: 2018-11-08T16:48:19-0500

Clinical Trials [2952 Associated Clinical Trials listed on BioPortfolio]

Trial of a Secondary Stroke Prevention Program

The purpose of this study is to determine whether an outpatient program can reduce the risk of recurrent stroke.

Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes

This umbrella protocol seeks to develop robust data registries for non-communicable diseases (NCDs) in sub-Saharan Africa (SSA) with the aim of providing accurate and comprehensive data fo...

Adapting Tools to Implement Stroke Risk Management to Veterans

The purpose of this study is to help us understand how a stroke prevention program can help improve control of medical conditions that increase the risk of having a stroke. A stroke preve...

Evaluation of a Handwashing Promotion Program in Chinese Elementary Schools

The purpose of this study is to determine the effects of a commercial hand washing promotion program on hygiene knowledge, attitudes, and practices, and on health outcomes such as reported...

Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients

Patients after TIA or Stroke are at high risk of experiencing a new stroke or myocardial infarction. Poor adherence to evidence based secondary prevention regimens is frequently seen. Supp...

PubMed Articles [14725 Associated PubMed Articles listed on BioPortfolio]

Cilostazol for treatment of cerebral infarction.

Stroke not only causes critical disability and death but is also a cause of anxiety with the possibility of secondary cardiovascular events including secondary ischemic stroke. Indeed, patients with a...

Clinical and demographic features of patients with stroke and atrial fibrillation.

Stroke takes the second place among all causes for cardiovascular death and the first place in mortality and disability among other nervous system diseases. Atrial fibrillation (AF) is presently is a ...

Practical Tips for Implementing the Diabetes Prevention Program in Clinical Practice.

The Diabetes Prevention Program (DPP) is an evidence-based lifestyle change program for prediabetes that is associated with a 58% reduction in 3-year diabetes incidence, and it has been supported by t...

Knowledge on cardiovascular risk factors and symptoms of stroke among inhabitants of rural communite.

Introduction: Stroke is one of the leading causes of mortality and disability in the world. A wide knowledge of risk factors for cerebrovascular diseases is one of the main elements of primary prevent...

Underuse of Oral Anticoagulants in Patients With Ischemic Stroke and Atrial Fibrillation in China.

Anticoagulant therapy is an effective stroke prevention measurement for subjects with atrial fibrillation (AF) who are at high risk of ischemic stroke. However, it is reported that oral anticoagulants...

Medical and Biotech [MESH] Definitions

Reporting of new and reemerging infectious diseases and studies that seek to improve the understanding of factors involved in disease emergence, prevention, and elimination.

Specific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from SECONDARY PREVENTION and TERTIARY PREVENTION.

A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.

Stroke caused by lacunar infarction or other small vessel diseases of the brain. It features hemiparesis (see PARESIS), hemisensory, or hemisensory motor loss.

Diseases of long duration and generally slow progression. The four main types of noncommunicable diseases are CARDIOVASCULAR DISEASES (e.g., heart attacks and stroke), CANCER, chronic respiratory diseases (e.g., CHRONIC OBSTRUCTIVE PULMONARY DISEASE and ASTHMA) and DIABETES MELLITUS.

More From BioPortfolio on "Make my Day - Primary Prevention of Stroke"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial